All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Estimating the number of colorectal cancer patients treated with anti-tumour therapy in 2015: the analysis of the Czech National Cancer Registry

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11140%2F12%3A10133074" target="_blank" >RIV/00216208:11140/12:10133074 - isvavai.cz</a>

  • Alternative codes found

    RIV/00216224:14110/12:00057270 RIV/00843989:_____/12:00102834 RIV/00669806:_____/12:10133074

  • Result on the web

    <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3315738/pdf/1471-2458-12-117.pdf" target="_blank" >http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3315738/pdf/1471-2458-12-117.pdf</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1186/1471-2458-12-117" target="_blank" >10.1186/1471-2458-12-117</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Estimating the number of colorectal cancer patients treated with anti-tumour therapy in 2015: the analysis of the Czech National Cancer Registry

  • Original language description

    Background: Colorectal cancer (CRC) represents a serious health care problem in the Czech Republic. The prevalence of patients requiring anti-tumour therapy is also of great importance, as it is directly associated with planning of health care resources.Methods: This work proposes a population-based model for the estimation of stage-specific prevalence of CRC patients who will require active anti-tumour therapy in a given year. Its applicability is documented on records of the Czech National Cancer Registry (CNCR), which is used to estimate the number of patients potentially treated with anti-tumour therapy in the Czech Republic in 2015. Results: Based on the scenarios, the model predicts an increase in CRC prevalence from 13% to 30% in comparison withthe situation in 2008. Moreover, the model predicts that 10,074 to 11,440 CRC patients will be indicated for anti-tumour therapy in the Czech Republic in 2015. Considering all patients with terminal cancer recurrence and all patients pri

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

  • CEP classification

    FD - Oncology and haematology

  • OECD FORD branch

Result continuities

  • Project

    Result was created during the realization of more than one project. More information in the Projects tab.

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2012

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    BMC Public Health

  • ISSN

    1471-2458

  • e-ISSN

  • Volume of the periodical

    12

  • Issue of the periodical within the volume

    117

  • Country of publishing house

    GB - UNITED KINGDOM

  • Number of pages

    10

  • Pages from-to

  • UT code for WoS article

    000302376800001

  • EID of the result in the Scopus database